Home / Intelligence / Webinars / Cracking the Code on Generative AI: From Hype to Impact
Available On Demand
Watched our AIML 101 webinar and ready to learn more? Trinity Life Sciences is excited to continue the conversation with our next webinar, which will dive deeper into how pharma companies can move beyond the hype to unlock the value of Generative AI (GenAI).
Join Trinity experts, Steve Laux, VP of Commercial Insights & Advanced Analytics, Nabha Subramanya, VP of Data Science and Patrick Waring, Director of New Products & Strategy, as they sift through all the noise surrounding GenAI and share real-life use cases and practical actions that you should be doing now to drive impact for your organization.
AIML is here. Be ready with Trinity.
Key Webinar Topics
- Examine the current landscape of GenAI in the pharma industry
- Explore real-life, practical use cases of GenAI in pharma, with a focus on what’s working and what’s not
- Address the challenges of implementing GenAI, such as the rapidly changing tech stack
- Prioritize use cases based on their potential value for your organization
- Learn about Trinity’s framework for evaluating and implementing GenAI
Featuring
Steven Laux
Vice President, Analytics &
Head of Generative AI
Nabha Subramanya
Vice President,
Data Science
Patrick Waring
Director,
New Products & Strategy
Complete the form below to view the on-demand webinar
By submitting this form, creating an account, and/or using our website (or using our Services) you agree to our Privacy Policy. Information provided by you is stored in our database and may be used for sending you additional information about Trinity (including Trinity’s partners and affiliates) and our products and services. Such information may be transferred for this purpose to Trinity and affiliates in other countries. If you would like to opt out in the future, please email _compliance@trinitylifesciences.com.
This webinar will be hosted within the ON24 platform, which requires the usage of Javascript and Cookies. Please see ON24’s Privacy Policy for more information.
*Gartner, Life Science CIOs: Reinvigorate Your D&A Capabilities With a Modern Commercial Intelligence Platform, Animesh Gandhi, published 13 May 2024.
GARTNER is a registered trademark and service mark of Gartner, Inc. and/or its affiliates in the U.S. and internationally. All rights reserved.
Gartner does not endorse any vendor, product or service depicted in its research publications, and does not advise technology users to select only those vendors with the highest ratings or other designation. Gartner research publications consist of the opinions of Gartner’s research organization and should not be construed as statements of fact. Gartner disclaims all warranties, expressed or implied, with respect to this research, including any warranties of merchantability or fitness for a particular purpose.
Related Intelligence
Blog
The Next Wave of Global AI Medical Devices: Innovation in Action
A recent bipartisan initiative by Senators Martin Heinrich, Mike Rounds, Marsha Blackburn and Todd Young urged the Centers for Medicare & Medicaid Services (CMS) to establish a formal payment pathway for algorithm-based health care services (ABHS). This move addresses the need for stable Medicare reimbursement for FDA-cleared AI and machine learning (ML) medical devices, which […]
Read More
Webinars
Human Centered Design Approach to GenAI for Life Sciences
Available On Demand
We need to think through not just whether GenAI works, but how we make it usable for people and impactful for our business… The next webinar in our “Making AI Real” webinar series will focus on people, process and technology—three interconnected components that are key to successful GenAI implementation. Join Trinity Life Sciences’ GenAI experts […]
Watch Now
Case Studies
HCP-level Site Alert Predictions
Trinity was able to develop an advanced machine learning algorithm to predict potential site alerts for HCPs in the target universe
Read More